patient-derived xenograft
-
Anti-CD38 Therapy with Daratumumab for Relapsed/Refractory CD20-Negative Diffuse Large B-Cell Lymphoma
P. Vockova, M. Svaton, J. Karolova, E. Pokorna, Martin Vokurka, Pavel Klener
2020, Vol. 66, Issue 1, pp. 17-23
